Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Intravenous Access Devices Market by PRODUCT (Intravenous Catheters, Centrally Inserted Catheters, Midline Peripheral Catheters, Intravenous Infusion Pumps, Intravenous Needles): Global Opportunity Analysis and Industry Forecast, 2023-2032

A00330

Pages: NA

Charts: NA

Tables: NA

Intravenous Access Devices are a prominent sector of the Healthcare industry. These devices are used by physicians for treating patients as well as testing blood after withdrawing it via intravenous route. Intravenous access devices are used for administering all the classes of drugs like antibiotics, antipyretics and analgesics. Rising incidences of different diseases such as tuberculosis, cancer and others are the key drivers of this market. Moreover, urbanization and growing geriatric population all over the world boost the growth of the Intravenous (IV) Access Devices market. 

Growing development of new vaccines and use of advanced technology to design new products are another driver for the market. However, lenient government regulations for approving Intravenous (IV) insulin infusion pumps and risks associated with using needles are the major restraints of this market. Furthermore, rise in the number of patients and increased disposable incomes among emerging countries are the key opportunities for this market.

Global Intravenous Access Devices Market Analysis by Product

On the basis of its types, an intravenous access devices market is segmented into Intravenous Catheters, Intravenous Infusion Pumps and Intravenous Needles. It is further subcategorized by the type of products. Intravenous catheters are one of the promising segments of Global Intravenous access devices market and it is expected to grow at healthy CAGR due to the rising incidences of diseases such as tuberculosis and cancer and the growing geriatric population worldwide.

Global Intravenous Access Devices Market Analysis by Geography

The intravenous access devices market is segmented according to geography into North America, Europe, Asia-Pacific and LAMEA. The North American region holds the dominant share in this market due to growing geriatric population and patient pool. However, the Asia-pacific region would have a high growth rate due to rise in target diseases, growing geriatric population, significant healthcare expenditure, and improving healthcare infrastructure.

Competitive Analysis

The key companies profiled in this report are Becton, Dickinson & Company, B. Braun Melsungen AG, Teleflex Incorporated, Medtronic, Inc., Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., CareFusion Corporation and Baxter International. The key developmental strategies for these companies are improving medication management, lowering the cost of their products, lowering the risk of infection and partnering with their customers in healthcare industries.

HIGH LEVEL ANALYSIS

Analysis of the market based on Porter’s Five Force model suggests that the bargaining power of the supplier is high as the patient pool is growing and these devices are used for many treatments and for diagnosis purposes. Threat of new entrants is low as the capital investment required for this market is high. Growth in the IV access device market and rise in target diseases has increased the demand for these devices for consistent disease monitoring. This has shaped the platform for leading companies to gain more competencies in the market.

KEY BENEFITS

  • The market is segmented by type of product, which would enable a deeper understanding of the scope for this market.
  • Geographic segmentation would enable stakeholders to make region specific plans for growth in untapped regions.
  • Analysis provides an overview of the market like its drivers, opportunities and restraints. Moreover, Porter’s Five Force Model and SWOT analysis are strategically discussed for the global intravenous access devices market.
  • The analysis assists in understanding the strategies adopted by the companies for the growth of the intravenous access devices market.

Key Market Segments

  • By PRODUCT
    • Intravenous Catheters
      • Midline Peripheral Catheter
      • Central Catheters
    • Centrally Inserted Catheters
    • Midline Peripheral Catheters
    • Intravenous Infusion Pumps
      • Parenteral Feeding Infusion Pumps
      • Intravenous Insulin Infusion pumps
      • Intravenous Syringe Infusion Pumps
      • Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps
    • Intravenous Needles
  • By GEOGRAPHY
    • North America
    • Europe
    • Asia Pacific
    • LAMEA


Key Market Players

  • CR Bard, Inc.
  • Gyroll GmbH.
  • Armetheon, Inc.
  • Smiths Medical
  • Fresenius Kabi AG
  • Medtronic
  • Teleflex Incorporated
  • ICU Medical, Inc.
  • Becton, Dickinson and Company (BD)
  • Vascular Solutions, Inc.
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: INTRAVENOUS ACCESS DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Intravenous Catheters

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Midline Peripheral Catheter

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Central Catheters

        • 4.2.4.1. Market Size and Forecast
    • 4.3. Centrally Inserted Catheters

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Midline Peripheral Catheters

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Intravenous Infusion Pumps

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

      • 4.5.4. Parenteral Feeding Infusion Pumps

        • 4.5.4.1. Market Size and Forecast
      • 4.5.4. Intravenous Insulin Infusion pumps

        • 4.5.4.1. Market Size and Forecast
      • 4.5.4. Intravenous Syringe Infusion Pumps

        • 4.5.4.1. Market Size and Forecast
      • 4.5.4. Intravenous Patient Controlled Analgesia (PCA) Infusion Pumps

        • 4.5.4.1. Market Size and Forecast
    • 4.6. Intravenous Needles

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

  • CHAPTER 5: INTRAVENOUS ACCESS DEVICES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Product

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Intravenous Access Devices Market

        • 5.2.4.1. Market Size and Forecast, By Product
      • 5.2.5. Canada Intravenous Access Devices Market

        • 5.2.5.1. Market Size and Forecast, By Product
      • 5.2.6. Mexico Intravenous Access Devices Market

        • 5.2.6.1. Market Size and Forecast, By Product
    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Product

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Intravenous Access Devices Market

        • 5.3.4.1. Market Size and Forecast, By Product
      • 5.3.5. Germany Intravenous Access Devices Market

        • 5.3.5.1. Market Size and Forecast, By Product
      • 5.3.6. Italy Intravenous Access Devices Market

        • 5.3.6.1. Market Size and Forecast, By Product
      • 5.3.7. Spain Intravenous Access Devices Market

        • 5.3.7.1. Market Size and Forecast, By Product
      • 5.3.8. UK Intravenous Access Devices Market

        • 5.3.8.1. Market Size and Forecast, By Product
      • 5.3.9. Russia Intravenous Access Devices Market

        • 5.3.9.1. Market Size and Forecast, By Product
      • 5.3.10. Rest Of Europe Intravenous Access Devices Market

        • 5.3.10.1. Market Size and Forecast, By Product
    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Product

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Intravenous Access Devices Market

        • 5.4.4.1. Market Size and Forecast, By Product
      • 5.4.5. Japan Intravenous Access Devices Market

        • 5.4.5.1. Market Size and Forecast, By Product
      • 5.4.6. India Intravenous Access Devices Market

        • 5.4.6.1. Market Size and Forecast, By Product
      • 5.4.7. South Korea Intravenous Access Devices Market

        • 5.4.7.1. Market Size and Forecast, By Product
      • 5.4.8. Australia Intravenous Access Devices Market

        • 5.4.8.1. Market Size and Forecast, By Product
      • 5.4.9. Thailand Intravenous Access Devices Market

        • 5.4.9.1. Market Size and Forecast, By Product
      • 5.4.10. Malaysia Intravenous Access Devices Market

        • 5.4.10.1. Market Size and Forecast, By Product
      • 5.4.11. Indonesia Intravenous Access Devices Market

        • 5.4.11.1. Market Size and Forecast, By Product
      • 5.4.12. Rest of Asia Pacific Intravenous Access Devices Market

        • 5.4.12.1. Market Size and Forecast, By Product
    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Product

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Intravenous Access Devices Market

        • 5.5.4.1. Market Size and Forecast, By Product
      • 5.5.5. South Africa Intravenous Access Devices Market

        • 5.5.5.1. Market Size and Forecast, By Product
      • 5.5.6. Saudi Arabia Intravenous Access Devices Market

        • 5.5.6.1. Market Size and Forecast, By Product
      • 5.5.7. UAE Intravenous Access Devices Market

        • 5.5.7.1. Market Size and Forecast, By Product
      • 5.5.8. Argentina Intravenous Access Devices Market

        • 5.5.8.1. Market Size and Forecast, By Product
      • 5.5.9. Rest of LAMEA Intravenous Access Devices Market

        • 5.5.9.1. Market Size and Forecast, By Product
  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning, 2024

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. Becton, Dickinson And Company (BD)

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Medtronic

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Teleflex Incorporated

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Vascular Solutions, Inc.

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. ICU Medical, Inc.

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. CR Bard, Inc.

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Fresenius Kabi AG

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Smiths Medical

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. Armetheon, Inc.

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Gyroll GmbH.

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR CENTRALLY INSERTED CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR MIDLINE PERIPHERAL CATHETERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS INFUSION PUMPS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS NEEDLES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. NORTH AMERICA INTRAVENOUS ACCESS DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 10. U.S. INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 11. CANADA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 12. MEXICO INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. EUROPE INTRAVENOUS ACCESS DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. EUROPE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. FRANCE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 16. GERMANY INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. ITALY INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 18. SPAIN INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 19. UK INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. RUSSIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 21. REST OF EUROPE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. ASIA-PACIFIC INTRAVENOUS ACCESS DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. ASIA-PACIFIC INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. CHINA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 25. JAPAN INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. INDIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 27. SOUTH KOREA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. AUSTRALIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. THAILAND INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. MALAYSIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 31. INDONESIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. REST OF ASIA PACIFIC INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 33. LAMEA INTRAVENOUS ACCESS DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 34. LAMEA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 35. BRAZIL INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 36. SOUTH AFRICA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. SAUDI ARABIA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 38. UAE INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. ARGENTINA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 40. REST OF LAMEA INTRAVENOUS ACCESS DEVICES, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. BECTON, DICKINSON AND COMPANY (BD): KEY EXECUTIVES
  • TABLE 42. BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
  • TABLE 43. BECTON, DICKINSON AND COMPANY (BD): OPERATING SEGMENTS
  • TABLE 44. BECTON, DICKINSON AND COMPANY (BD): PRODUCT PORTFOLIO
  • TABLE 45. BECTON, DICKINSON AND COMPANY (BD): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 46. MEDTRONIC: KEY EXECUTIVES
  • TABLE 47. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 48. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 49. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 50. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 51. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 52. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 53. TELEFLEX INCORPORATED: OPERATING SEGMENTS
  • TABLE 54. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 55. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 56. VASCULAR SOLUTIONS, INC.: KEY EXECUTIVES
  • TABLE 57. VASCULAR SOLUTIONS, INC.: COMPANY SNAPSHOT
  • TABLE 58. VASCULAR SOLUTIONS, INC.: OPERATING SEGMENTS
  • TABLE 59. VASCULAR SOLUTIONS, INC.: PRODUCT PORTFOLIO
  • TABLE 60. VASCULAR SOLUTIONS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 61. ICU MEDICAL, INC.: KEY EXECUTIVES
  • TABLE 62. ICU MEDICAL, INC.: COMPANY SNAPSHOT
  • TABLE 63. ICU MEDICAL, INC.: OPERATING SEGMENTS
  • TABLE 64. ICU MEDICAL, INC.: PRODUCT PORTFOLIO
  • TABLE 65. ICU MEDICAL, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 66. CR BARD, INC.: KEY EXECUTIVES
  • TABLE 67. CR BARD, INC.: COMPANY SNAPSHOT
  • TABLE 68. CR BARD, INC.: OPERATING SEGMENTS
  • TABLE 69. CR BARD, INC.: PRODUCT PORTFOLIO
  • TABLE 70. CR BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 71. FRESENIUS KABI AG: KEY EXECUTIVES
  • TABLE 72. FRESENIUS KABI AG: COMPANY SNAPSHOT
  • TABLE 73. FRESENIUS KABI AG: OPERATING SEGMENTS
  • TABLE 74. FRESENIUS KABI AG: PRODUCT PORTFOLIO
  • TABLE 75. FRESENIUS KABI AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. SMITHS MEDICAL: KEY EXECUTIVES
  • TABLE 77. SMITHS MEDICAL: COMPANY SNAPSHOT
  • TABLE 78. SMITHS MEDICAL: OPERATING SEGMENTS
  • TABLE 79. SMITHS MEDICAL: PRODUCT PORTFOLIO
  • TABLE 80. SMITHS MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. ARMETHEON, INC.: KEY EXECUTIVES
  • TABLE 82. ARMETHEON, INC.: COMPANY SNAPSHOT
  • TABLE 83. ARMETHEON, INC.: OPERATING SEGMENTS
  • TABLE 84. ARMETHEON, INC.: PRODUCT PORTFOLIO
  • TABLE 85. ARMETHEON, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. GYROLL GMBH.: KEY EXECUTIVES
  • TABLE 87. GYROLL GMBH.: COMPANY SNAPSHOT
  • TABLE 88. GYROLL GMBH.: OPERATING SEGMENTS
  • TABLE 89. GYROLL GMBH.: PRODUCT PORTFOLIO
  • TABLE 90. GYROLL GMBH.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 3. SEGMENTATION INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALINTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 11. INTRAVENOUS ACCESS DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. INTRAVENOUS ACCESS DEVICES MARKET FOR CENTRALLY INSERTED CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. INTRAVENOUS ACCESS DEVICES MARKET FOR MIDLINE PERIPHERAL CATHETERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS INFUSION PUMPS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. INTRAVENOUS ACCESS DEVICES MARKET FOR INTRAVENOUS NEEDLES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 18. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 20. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 21. COMPETITIVE DASHBOARD
  • FIGURE 22. COMPETITIVE HEATMAP: INTRAVENOUS ACCESS DEVICES MARKET
  • FIGURE 23. TOP PLAYER POSITIONING, 2024
  • FIGURE 24. BECTON, DICKINSON AND COMPANY (BD): NET SALES, 2022-2024 ($MILLION)
  • FIGURE 25. BECTON, DICKINSON AND COMPANY (BD): REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 26. BECTON, DICKINSON AND COMPANY (BD): REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 27. MEDTRONIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 28. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 29. MEDTRONIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 30. TELEFLEX INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. VASCULAR SOLUTIONS, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. VASCULAR SOLUTIONS, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. VASCULAR SOLUTIONS, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. ICU MEDICAL, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. ICU MEDICAL, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. ICU MEDICAL, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. CR BARD, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. CR BARD, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. CR BARD, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. FRESENIUS KABI AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. FRESENIUS KABI AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. FRESENIUS KABI AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. SMITHS MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. ARMETHEON, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. ARMETHEON, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. ARMETHEON, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. GYROLL GMBH.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. GYROLL GMBH.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. GYROLL GMBH.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Intravenous Access Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue